Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Reaffirms Forecast; Plans IPO for Mead Johnson Nutritionals
Tweet Send to a Friend
Bristol-Myers Squibb Co. (NYSE: BMY) reports Q1 EPS of $0.42 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
